Free Trial

Knight Therapeutics (GUD) Earnings Date, Estimates & Call Transcripts

Knight Therapeutics logo
C$5.65
+0.01 (+0.18%)
(As of 11/1/2024 ET)

Knight Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 7Before Market OpensConfirmed
Actual EPS
(Aug. 8)
-C$0.02 Missed By -C$0.05
Consensus EPS
(Aug. 8)
C$0.03

Knight Therapeutics posted Q2 2024 earnings on August 8, 2024, reporting an EPS of -C$0.02, which missed the consensus estimate of C$0.03 by C$0.05. Quarterly revenue was reported to be C$95.57 million, above the consensus estimate of C$89.83 million. With a trailing EPS of -C$0.20,

GUD Upcoming Earnings

Knight Therapeutics' next earnings date is scheduled for Thursday, November 7, 2024.

Get Knight Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Knight Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GUD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GUD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Knight Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-C$0.01-C$0.01-C$0.01
Q2 20241C$0.01C$0.01C$0.01
Q3 20242-C$0.01C$0.06C$0.03
Q4 20241C$0.00C$0.00C$0.00
FY 20245-C$0.01C$0.06C$0.03
Q1 20251C$0.00C$0.00C$0.00
Q2 20251C$0.01C$0.01C$0.01
Q3 20251C$0.01C$0.01C$0.01
Q4 20251C$0.01C$0.01C$0.01
FY 20254C$0.03C$0.03C$0.03

Knight Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/7/2024
(Confirmed)
------- 
8/8/2024Q2 2024C$0.03C-$0.02 -C$0.05C-$0.02C$89.83MC$95.57M
5/9/2024Q1 2024C$0.02C-$0.04 -C$0.06C-$0.04C$80.27MC$86.60M
3/21/2024Q4 2023C$0.02C-$0.03 -C$0.05C$0.17C$78.37MC$74.20M
11/9/2023Q3 2023C$0.03C$0.09+C$0.06C$0.09C$72.00MC$81.50M
8/10/2023Q2 2023C$0.03C$0.02 -C$0.01C$0.02C$80.15MC$89.91M
5/11/2023Q1 2023-C-$0.04 -C$0.04C-$0.04C$74.80MC$82.60M
3/23/2023Q4 2022-C$0.02+C$0.02C$0.17C$62.00MC$81.66M
11/10/2022Q3 2022C-$0.01C$0.02+C$0.03C$0.03C$67.03MC$72.28M


This page (TSE:GUD) was last updated on 11/3/2024 by MarketBeat.com Staff
From Our Partners